Human Molecular Genetics, Vol 6, 337-347, Copyright © 1997 by Oxford University Press
AP Shuber, LA Michalowsky, GS Nass, J Skoletsky, LM Hire, SK Kotsopoulos, MF Phipps, DM Barberio and KW Klinger
As more mutations are identified in genes of known sequence, there is a
crucial need in the areas of medical genetics and genome analysis for
rapid, accurate and cost-effective methods of mutation detection. We have
developed a multiplex allele-specific diagnostic assay (MASDA) for analysis
of large numbers of samples (> 500) simultaneously for a large number of
known mutations (> 100) in a single assay. MASDA utilizes
oligonucleotide hybridization to interrogate DNA sequences. Multiplex DNA
samples are immobilized on a solid support and a single hybridization is
performed with a pool of allele-specific oligonucleotide (ASO) probes. Any
probes complementary to specific mutations present in a given sample are in
effect affinity purified from the pool by the target DNA. Sequence-specific
band patterns (fingerprints), generated by chemical or enzymatic sequencing
of the bound ASO(s), easily identify the specific mutation(s). Using this
design, in a single diagnostic assay, we tested samples for 66 cystic
fibrosis (CF) mutations, 14 beta-thalassemia mutations, two sickle cell
anemia (SCA) mutations, three Tay-Sachs mutations, eight Gaucher mutations,
four mutations in Canavan disease, four mutations in Fanconi anemia, and
five mutations in BRCA1. Each mutation was correctly identified. Finally,
in a blinded study of 106 of these mutations in > 500 patients, all
mutations were properly identified. There were no false positives or false
negatives. The MASDA assay is capable of detecting point mutations as well
as small insertion or deletion mutations. This technology is amenable to
automation and is suitable for immediate utilization for high-throughput
genetic diagnostics in clinical and research laboratories.
ARTICLES
High throughput parallel analysis of hundreds of patient samples for more than 100 mutations in multiple disease genes
Department of Technology Development, Genzyme Genetics, Framingham, MA 01701-9322, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Iohom, D. Fitzgerald, and A. J. Cunningham Principles of pharmacogenetics--implications for the anaesthetist Br. J. Anaesth., September 1, 2004; 93(3): 440 - 450. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jobs, W. M. Howell, L. Stromqvist, T. Mayr, and A. J. Brookes DASH-2: Flexible, Low-Cost, and High-Throughput SNP Genotyping by Dynamic Allele-Specific Hybridization on Membrane Arrays Genome Res., May 1, 2003; 13(5): 916 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Wilhelmsson, B. Norden, K. Mukherjee, M. T. Dulay, and R. N. Zare Genetic screening using the colour change of a PNA-DNA hybrid-binding cyanine dye Nucleic Acids Res., January 15, 2002; 30(2): e3 - e3. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Landegren, M. Nilsson, and P.-Y. Kwok Reading Bits of Genetic Information: Methods for Single-Nucleotide Polymorphism Analysis Genome Res., August 1, 1998; 8(8): 769 - 776. [Full Text]
|
|